TA
Tamarack Advisers’s NovoCure NVCR Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | – | Sell |
-150,000
| Closed | -$9.64M | – | 30 |
|
2019
Q2 | $9.64M | Buy |
+150,000
| New | +$9.64M | 2.93% | 14 |
|
2019
Q1 | – | Sell |
-670,000
| Closed | -$22.4M | – | 22 |
|
2018
Q4 | $22.4M | Buy |
670,000
+35,000
| +6% | +$1.17M | 9.15% | 4 |
|
2018
Q3 | $33.4M | Sell |
635,000
-465,000
| -42% | -$24.5M | 9.54% | 2 |
|
2018
Q2 | $34.4M | Sell |
1,100,000
-15,000
| -1% | -$470K | 11.53% | 1 |
|
2018
Q1 | $24.3M | Buy |
1,115,000
+60,000
| +6% | +$1.31M | 11.56% | 1 |
|
2017
Q4 | $21.3M | Buy |
1,055,000
+311,446
| +42% | +$6.29M | 11.63% | 1 |
|
2017
Q3 | $14.8M | Sell |
743,554
-161,446
| -18% | -$3.2M | 9.04% | 2 |
|
2017
Q2 | $15.7M | Sell |
905,000
-85,750
| -9% | -$1.48M | 9.14% | 2 |
|
2017
Q1 | $8.03M | Buy |
990,750
+165,750
| +20% | +$1.34M | 5.01% | 7 |
|
2016
Q4 | $6.48M | Buy |
825,000
+50,000
| +6% | +$392K | 4.58% | 12 |
|
2016
Q3 | $6.56M | Buy |
+775,000
| New | +$6.56M | 2.06% | 17 |
|